US Patent Issued to AGENEBIO on May 6 for "Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment" (Pennsylvania, New Jersey, New York Inventors)

ALEXANDRIA, Va., June 10 -- United States Patent no. 12,291,535, issued on May 6, was assigned to AGENEBIO INC. (Baltimore).

"Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment" was invented by Belew Mekonnen (Gilbertsville, Pa.), John A. Butera (Clarksburg, N.J.), Jianxing Huang (Bethlehem, Pa.), Hemantbhai Patel (Piscataway, N.J.), Qin Jiang (Latham, N.Y.), Robert Jason Herr (Voorheesville, N.Y.), Emily Elizabeth Freeman (Voorheesville, N.Y.) and Nicholas James Mayhew (Niskayuna, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention relates to benzodiazepine derivatives, compositions comprising therapeutically effective amounts of those derivatives and meth...